Annual Review of Medicine 2017-01-18

Lysosomal Proteins as a Therapeutic Target in Neurodegeneration

Jessica M. Mc Donald, Dimitri Krainc

Index: 10.1146/annurev-med-050715-104432

Full Text: HTML

Abstract

Several proteins that are mutated in lysosomal storage diseases are linked to neurodegenerative disease. This review focuses on some of these lysosomal enzymes and transporters, as well as current therapies that have emerged from the lysosomal storage disease field. Given the deeper genetic understanding of lysosomal defects in neurodegeneration, we explore why some of these orphan disease drug candidates are also attractive targets in subpopulations of individuals with neurodegenerative disease.

Latest Articles:

Gene Editing: A New Tool for Viral Disease

2017-01-18

[10.1146/annurev-med-051215-031129]

The Type I Interferonopathies

2017-01-18

[10.1146/annurev-med-050715-104506]

Esophageal Adenocarcinoma: Screening, Surveillance, and Management

2017-01-18

[10.1146/annurev-med-050715-104218]

Management of Rectal Cancer Without Radical Resection

2017-01-18

[10.1146/annurev-med-062915-021419]

The End of Nihilism: Systemic Therapy of Advanced Non–Small Cell Lung Cancer

2017-01-18

[10.1146/annurev-med-042915-102442]

More Articles...